KalVista Pharmaceuticals (KALV) Total Liabilities (2016 - 2024)
Historic Total Liabilities for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $130.5 million.
- KalVista Pharmaceuticals' Total Liabilities changed N/A to $130.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $130.5 million, marking a year-over-year change of. This contributed to the annual value of $28.8 million for FY2024, which is N/A changed from last year.
- Per KalVista Pharmaceuticals' latest filing, its Total Liabilities stood at $130.5 million for Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Total Liabilities ranged from a high of $130.5 million in Q4 2024 and a low of $7.6 million during Q1 2021
- In the last 4 years, KalVista Pharmaceuticals' Total Liabilities had a median value of $22.6 million in 2023 and averaged $27.8 million.
- As far as peak fluctuations go, KalVista Pharmaceuticals' Total Liabilities tumbled by 5897.45% in 2020, and later skyrocketed by 3049.01% in 2024.
- Over the past 4 years, KalVista Pharmaceuticals' Total Liabilities (Quarter) stood at $10.5 million in 2020, then fell by 27.01% to $7.6 million in 2021, then surged by 217.98% to $24.3 million in 2023, then soared by 436.93% to $130.5 million in 2024.
- Its last three reported values are $130.5 million in Q4 2024, $26.8 million for Q4 2024, and $27.4 million during Q3 2024.